Roflumilast prevented tissue damage caused by lipopolysaccharide-induced sepsis via anti-inflammatory action
Demet Yalçın Kehribar, Lale Saka Baraz, Seda Kırmızıkan, Emre Soner Tiryaki, Mustafa Nusret Çiçekli, Bahattin Avcı, Caner Günaydın · 2026
Read Roflumilast prevented tissue damage caused by lipopolysaccharide-induced sepsis via anti-inflammatory action by Demet Yalçın Kehribar, Lale Saka Baraz, Seda Kırmızıkan, Emre Soner Tiryaki, Mustafa Nusret Çiçekli, Bahattin Avcı, Caner Günaydın (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350653.txt.
Description
Demet Yalçın Kehribar and co-authors tested the lung drug roflumilast against sepsis like injury in rats in 2026. Sepsis, a runaway response to infection, damages many organs, and a bacterial toxin is a standard way to model it in animals.
Rats given the toxin showed high inflammation markers and harm to liver, kidney, and other tissues. A lower drug dose did nothing clear, but the higher dose cut inflammation signals, eased tissue damage, and lowered a kidney injury marker. The dose contrast is the story: protection appeared only at the stronger dose, a caution for any move toward patients.
Catalog record
| CREATOR | Demet Yalçın Kehribar, Lale Saka Baraz, Seda Kırmızıkan, Emre Soner Tiryaki, Mustafa Nusret Çiçekli, Bahattin Avcı, Caner Günaydın |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23021 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |